-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/does-use-of-generic-medications-for-seizures-result-in-poorer-control-more-er-visits-and-or-hospitalizations-than-the-use-of-brand-name-medications
November 01, 2017 - yes
If yes, explain the specific technologies, devices, drugs, or interventions you would like to … come out against the substitution of "A" rated generics and neurologists use a large amount of brand drugs … In addition many states include these drugs in their narrow therapeutic index laws. … If there is in fact a difference between the therapeutic effect of these drugs then more rational and
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/the-american-college-of-chest-physicians-accp-proposes-to-update-the-medical-therapies-section-of-2007-updated-publication-on-medical-therapies-for-pulmonary-arterial-hypertension-accp-evidence-based-clinical-practice-guidel
November 01, 2017 - yes
If yes, explain the specific technologies, devices, drugs, or interventions you would like to … see compared:
2 new drugs have now been approved for the treatment of PAH:
inhaled treprostinil … ambrisentan
Comparisons should be made between these new drugs and the older ones, listed here … Side effects of various drugs include but are not limited to liver function abnormalities, elevated serum … Since the 2007 update of the medical therapies section of the 2004 guidelines, 2 new drugs have been
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
May 19, 2010 - These drugs have been studied for
off-label use in several conditions. … published studies on
atypical antipsychotics and found that the most common off-label uses of the drugs … treatment for agitation in dementia, association between the increased risk of death
and antipsychotics drugs … Sub-Question 2: How do atypical antipsychotic medications compare with other
drugs, including first … How do they compare within the class and with other
drugs used for the conditions?
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
October 01, 2015 - Cambridge (MA): Vertex
Pharmaceuticals, Inc.; 2011 Nov 03 [accessed 2014
Apr 10]. [4 p]. … Cambridge (MA): Vertex
Pharmaceuticals, Inc.; 2010 Nov 08 [accessed 2011
Jan 04]. [1 p]. … Boston (MA): Vertex Pharmaceuticals, Inc.; 2014
Nov 05 [accessed 2014 Dec 11]. [3 p]. … Boehringer Ingelheim Pharmaceuticals, Inc. … Ridgefield (CT):
Boehringer Ingelheim Pharmaceuticals, Inc.; 2014
Oct. 18 p.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
January 01, 2012 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … These drugs will likely face intense scrutiny, considering the
challenges of accurately diagnosing
-
effectivehealthcare-admin.ahrq.gov/health-topics/prescription-drug-abuse
November 27, 2017 - Using the medicine for another purpose, such as getting high
Abusing some prescription drugs can … People who abuse these drugs may not understand the risks.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
November 01, 2013 - Regulatory Documents
Reviews of Drugs Compared With Devices
Drugs and devices are both regulated by … • Reviewers should search Drugs@FDA for information on drugs; if a search is not
conducted reviewers … However, the Web site typically does not have
documents related to older drugs and very new drugs. … International Conference on Harmonisation of
Technical Requirements for Registration of
Pharmaceuticals … For
drugs: generic name, or temporary identifier for drugs that do not yet have a generic name;
for
-
effectivehealthcare-admin.ahrq.gov/products/osteoporosis-bone-fracture/research-protocol
March 01, 2020 - Controlled clinical trials that report fracture outcomes for one or more of the drugs of interest will … Articles of any study design that report on adherence/persistence for any of the drugs of interest will … In our search to identify clinical studies of drugs of interest to this review, we will use terms for … osteoporosis, osteopenia, low bone density, and the drugs listed in the key questions (as well as any … In our search for the key AE, we will use terms for the AE and each of the drugs of interest for this
-
effectivehealthcare-admin.ahrq.gov/products/hypertension-treatment-knowledge-gaps/abstract
December 01, 2019 - Commonly used two classes of drugs, angiotensin converting enzyme inhibitors (ACEIs) and angiotensin … actionable information for patients, physicians and policy makers to make decision in uses of these drugs
-
effectivehealthcare-admin.ahrq.gov/health-topics/dementia
February 19, 2025 - Drugs are available to treat some of these diseases. … While these drugs cannot cure dementia or repair brain damage, they may improve symptoms or slow down
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - San Diego (CA): Arena
Pharmaceuticals, Inc; 2010 Nov 9 [accessed 2011
Dec 16]. [3 p]. … New data from Arena Pharmaceuticals' pivotal
BLOSSOM trial of lorcaserin demonstrate
improvements … Washington (DC): Arena
Pharmaceuticals, Inc.; 2009 Oct 27 [accessed
2011 Apr 21]. [4 p]. … San
Diego (CA): Arena Pharmaceuticals; 2012 Jun 27
[accessed 2012 Jul 5]. [4 p]. … Arena Pharmaceuticals. Lorcaserin
hydrochloride. Drugs Future. 2007;32(9):766-70.
78.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
January 01, 2012 - In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … The search is on for ways to definitively diagnose AD and for drugs, biologics, and alternative
or … Peripheral and Central Nervous System Drugs
Advisory Committee.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
April 01, 2020 - Finally, although only a few prescription
drugs are approved by the U.S. … – There was minimal evidence addressing
whether efficacy of prescription drugs for
CATD treatment … (n=454),
and five that compared prescription drugs with
supplements (n=258). … Two trials compared different
prescription drugs (n=414). … Evidence on the efficacy and harms of CATD
drugs had several limitations.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
January 01, 2012 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Vertex Pharmaceuticals Incorporated. … Vertex Pharmaceuticals Incorporated.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
February 01, 2009 - .10 Another
observational study found higher mortality in those given haloperidol vs. two atypical drugs … FDA warns antipsychotic drugs
may be risky for elderly. JAMA
2005;293:2462.
3. Strong C. … Using antipsychotic agents in older
patients: expert consensus panel for using
antipsychotic drugs … Antipsychotic
drugs: prolonged QTc Interval, Torsade de
Pointes, and sudden death. … Antipsychotic
drugs in dementia: what should be made of
the risks? JAMA 2005;294:1963-1965.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_executive.pdf
April 01, 2012 - The
absolute risk difference in continence was less than
20 percent for all drugs. … Adverse effects were
common with all drugs and varied between the drugs. … Treatment
discontinuation due to adverse effects of drugs is
common. … Benefits and harms with drugs did not differ
by individual quality criteria. … • Drugs for urgency UI demonstrated similar
effectiveness.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … The topic,
buprenorphine implant (Probuphine,™ Titan Pharmaceuticals, Inc., South San Francisco, CA
-
effectivehealthcare-admin.ahrq.gov/products/urinary-incontinence-treatment/research-protocol
December 01, 2020 - Harms:
Adverse events resulting from drugs. … Adrenergic drugs for urinary incontinence in adults. … Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. … Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. … delirium/confusional state; urinary tract infection (symptomatic); atrophic urethritis/vaginitis; use of pharmaceuticals
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
January 01, 2017 - and in 2013 for SGA versus
SGA drugs. … in effects
associated with individual drugs. … This analysis found that all of the drugs
included were superior to placebo. … The newer drugs
primarily have evidence only for symptom-based outcomes
and adverse events. … • Ensure comparable dosing with the best dosing titration
methods for all drugs included.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
January 01, 2013 - CER #51:
Dietary Supplements in Adults Taking Cardiovascular
Drugs
Original release date:
April … ................................ 5
1
Dietary Supplements in Adults Taking Cardiovascular
Drugs … Comparative Effectiveness Review (CER) #51, Dietary Supplements in Adults Taking
Cardiovascular Drugs … Dietary
Supplements in Adults Taking
Cardiovascular Drugs. … OR exp Phytotherapy/ or
exp Plant Preparations/ or exp Plant Extracts/ or exp Drugs, Chinese Herbal/